"XEPTAGEN SpA - Product Pipeline Analysis" Now Available at Fast Market Research
XEPTAGEN SpA (XEPTAGEN) is a medical device company, based in Italy. The company discovers novel molecular markers to produce diagnostic kits for the early detection, monitoring, and screening of cancerous cells. It develops the products for the treatments of liver cancer, colorectal cancer, prostate cancer and squamous cell carcinomas. XEPTAGEN products are marketed under the brand name HEPA AB, HEPA IC, HEPA AFPIC, COLONIC, PROSTATEIC and SCCALISA. The company uses proprietary platform technology called Combinatorial Proteomic to discover specific tumor...
View full press release